Research

Pages Tagged with "Research"

New radiotherapy targets tumors in real time
City of Hope is the first health system in Southern California to offer patients diagnosed with primary or metastatic lung and bone cancer a new form of radiotherapy that can...
Biomarkers may help detect prostate cancer risk in Black men
Scientists at City of Hope have identified a cell metabolism process found in men with diabetes and metastatic prostate cancer that could one day lead to improved testing and treatments...
City of Hope receives $32M grant to advance novel therapies
Researchers at City of Hope have been awarded $32.3 million from the California Institute for Regenerative Medicine (CIRM) to support three novel Phase 1 clinical trials evaluating innovative cell and...
CAR T cell therapy trial targets advanced ovarian cancer
Very few effective treatment options are available for patients with recurrent ovarian cancer and other solid tumors, but researchers are trying to change that.  Saul Priceman, Ph.D. Scientists at City of Hope recently...
Targeted chemotherapy kills all tumor cells in preclinical research
Could a new molecule targeting a protein called PCNA help scientists develop a cancer-stopping pill? New preclinical research suggests it may be possible. Researchers aimed at a protein once thought to...
Riggs Institute welcomes new diabetes researcher
Noted diabetes researcher Adolfo Garcia-Ocaña, Ph.D., has joined City of Hope as the new chair of the Department of Molecular & Cellular Endocrinology within the Arthur Riggs Diabetes &...
The latest advances in preventing and treating gastric cancer
Gastric, or stomach, cancer is relatively rare in the United States, striking about 27,000 people each year, accounting for less than 2% of all cancer cases.  But gastric cancer is...
Patient who achieved HIV remission shares his story
In the early 1980s, City of Hope patient Paul Edmonds went to a bar in San Francisco regularly after work, and often cried.Edmonds recalled reading the obituaries of many...
Novel radiation therapy zeros in on tough-to-treat cancers
City of Hope scientists have developed a remarkable new antibody with the unremarkable name M5A. It can precisely target the antigen CEA, a marker expressed by many types of...
Targeting glioblastoma with a cancer-killing virus
Glioblastoma is a virtually incurable brain cancer with a five-year-survival rate of only 10%.    “It’s heartbreaking to keep telling people in clinic that we don’t have a cure,” said...